Aspen Aerogels (NYSE:ASPN) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday.
According to Zacks, “Aspen Aerogels, Inc. is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in large-scale energy infrastructure facilities. The Company offers insulation for high temperature steam pipes, vessels, and equipment. Aspen serves petrochemical, refinery, industrial, and power generation sectors. It manufactures Cryogel (R), Pyrogel (R) and Spaceloft (R) products. Aspen Aerogels, Inc. is headquartered in Northborough, Massachusetts. “
Shares of Aspen Aerogels (ASPN) opened at $5.06 on Wednesday. Aspen Aerogels has a 12 month low of $3.84 and a 12 month high of $5.14. The company has a market capitalization of $119.60, a price-to-earnings ratio of -5.06 and a beta of 1.09.
In related news, major shareholder Craig A. Huff sold 2,895,981 shares of Aspen Aerogels stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $4.30, for a total value of $12,452,718.30. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 16.80% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of ASPN. Quantum Capital Management grew its holdings in shares of Aspen Aerogels by 1,552.9% in the 3rd quarter. Quantum Capital Management now owns 223,966 shares of the construction company’s stock worth $974,000 after acquiring an additional 210,416 shares during the last quarter. Essex Investment Management Co. LLC acquired a new position in shares of Aspen Aerogels in the 3rd quarter worth $823,000. Oaktop Capital Management II L.P. grew its holdings in shares of Aspen Aerogels by 14.6% in the 3rd quarter. Oaktop Capital Management II L.P. now owns 1,399,001 shares of the construction company’s stock worth $6,086,000 after acquiring an additional 177,953 shares during the last quarter. Royce & Associates LP grew its holdings in shares of Aspen Aerogels by 41.6% in the 2nd quarter. Royce & Associates LP now owns 585,954 shares of the construction company’s stock worth $2,607,000 after acquiring an additional 172,030 shares during the last quarter. Finally, Harvey Partners LLC grew its holdings in shares of Aspen Aerogels by 32.2% in the 3rd quarter. Harvey Partners LLC now owns 379,100 shares of the construction company’s stock worth $1,649,000 after acquiring an additional 92,432 shares during the last quarter. Institutional investors and hedge funds own 74.40% of the company’s stock.
WARNING: This piece was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2018/01/05/aspen-aerogels-aspn-rating-lowered-to-hold-at-zacks-investment-research.html.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.